AT1 2.63% 2.0¢ atomo diagnostics limited

Ann: Atomo receives approval for its COVID-19 antigen test in NZ, page-5

  1. 319 Posts.
    lightbulb Created with Sketch. 68
    Does read as though the approval covers the sales to 'professional or self test use' 'but I don't know enough about the regulatory structure of the NZ medical device approvals market. TBH I wasn't even aware we made an application to the TGA equivalent in NZ lol.
    https://hotcopper.com.au/data/attachments/4025/4025914-87170f568bb486e1e603b81bd5452ca0.jpg

    Though, reading over the announcement of the AccessBio renegotiated supply agreement it does indicate that AT1 has a right to only sell the POC (professional use) RAT in Aus and NZ. This right is not extended to the sales of the 10million self-use tests in the NZ market. See below

    https://hotcopper.com.au/data/attachments/4025/4025935-632f43100aa0322177a770c47ce8fef1.jpg

 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
0.001(2.63%)
Mkt cap ! $12.14M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $98 5K

Buyers (Bids)

No. Vol. Price($)
7 777274 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 431397 5
View Market Depth
Last trade - 14.53pm 18/09/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.